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Granular Cell Tumours are rare mesenchymal soft tissue tumours that arise throughout the body and are believed to be of neural
origin. They often present as asymptomatic, slow-growing, benign, solitary lesions but may be multifocal. 1-2% of cases are
malignant and can metastasise. Described series in the literature are sparse. We identiﬁed eleven cases in ten patients treated
surgically and followed-up for a period of over 6 years in our regional bone and soft tissue tumour centre. Five tumours were
located in the lower limb, four in the upper limb, and two in the trunk. Mean patient age was 31.2 years (range 8–55 years).
Excision was complete in one case, marginal in ﬁve cases and intralesional in ﬁve cases. No patients required postoperative
adjuvant treatment. Mean follow-up was 19.3 months (range 1–37 months). One case was multifocal, but there were no cases of
local recurrence or malignancy. Histopathological and immunohistochemical analysis revealed the classical granular cell tumour
features in all cases. We believe this case series to be the largest of its type in patients presenting to an orthopaedic soft tissue
tumour unit. We present our ﬁndings and correlate them with ﬁndings of other series in the literature.
Copyright © 2009 Barry Rose et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
GranularcelltumourwasoriginallydescribedintheGerman
literature as granular cell myoblastoma in 1926 [1]. Current
opinion considers the tumour to be neural in origin [2,
3].
Clinically, these tumours are rare and account for
approximately 0.5% of all soft tissue tumours [4]. Most
of the published experience arises from sparsely presented
case reports and few small series [4–7]. For the most part,
granular cell tumours behave in a benign fashion, but have
a tendency to recur. They can be multifocal at presentation.
They can arise anywhere in the body, typically in the
superﬁcial tissues (dermis and subcutis), along mucosal
surfaces and occasionally within skeletal muscle. In rare
cases they can metastasise, particularly when they arise in
deep to fascia or are over 4cm in diameter [7]. Malignant
transformation is rare but well recognised.
2.MaterialsandMethods
A retrospective review of our database was carried out.
All patients with a diagnosis of granular cell tumour were
included in the study. Our study covered the period 2002–
2008. All patients underwent preoperative MRI scanning.
Patients were treated with either core needle biopsy followed
by wide local excision or by excision biopsy.
3. Results
Results are presented in Table 1.E l e v e nt u m o u r sw e r e
identiﬁed in ten patients, all located within the soft tissues.
There was one male patient and nine female patients. The
mean age was 31.2 years (range 8–55 years). Five tumours
were located in the lower limb (three thigh, two calf), four
in the upper limb (two arm, one forearm, one ﬁnger),
and two within the trunk (one thoracic spine musculature,2 Sarcoma
Table 1: Patient data and histological features
a.
Patient Age Tumour location Size in mm (widest
diameter)
Depth Resection Margin (mm) Atypia Malignancy
13 9 Thigh 20 SC 1 N N
21 1 Calf 40 IM Intralesional N N
33 0 Forearm 20 SC Intralesional N N
43 7 Arm U SC 1 N N
53 7 Calf 22 IM 1 N N
62 9 Deltoid 35 IM 1 N N
74 0 Thigh 42 SC Intralesional Y N
85 5 Thigh 20 SC 7 N N
98 Finger 10 SC Intralesional N N
10a 26 Posterior thoracic
spine musculature 130 IM Intralesional N N
10b 26 Supraclavicular 40 IM 1 Y N
U: unrecorded; SC: subcutaneous; IM: intramuscular; Y: Yes; N: No.
apatient 10 presented with distant recurrence.
one supraclavicular fossa). Six of the resected lesions were
subcutaneous (54.5%) and ﬁve intramuscular (45.5%). The
history of symptom duration was available in nine out of
eleven patients, with a mean of 10.3 months (range 3–24
months).
Seven cases had a preoperative core needle biopsy
(63.3%), and four underwent excision biopsy. All tumours
were treated with surgical excision. Eighteen resection and
biopsy specimens were therefore examined.
The core needle biopsy was successful in diagnosing
granular cell tumour in all cases. Excision was wide (7mm
margin) in one resection case (9.1%), marginal in ﬁve
cases (45.5%), and intralesional in the remaining ﬁve cases
(45.5%). Marginally excised cases all had a 1mm margin
of normal tissue. The mean diameter of the tumours was
38.4mm (range 10–130mm).
In all cases histopathological examination showed the
classical features of granular cell tumour, the hallmark of
which is the ﬁnding of large cells containing a ﬁnely granular
cytoplasm(Figures1and2).Allspecimenswerebenign,with
two (diameters 40mm and 42mm) displaying pathological
features of atypia (necrosis, vesicular nuclei with large nucle-
oli, pleomorphism, increased mitotic rate). As described by
Fanburg-Smith et al., six histologic criteria are important
in deﬁning malignancy in granular cell tumours: necrosis,
cell spindling, vesicular nuclei with large nucleoli, increased
mitotic rate (>2/10 high-power ﬁelds), high nuclear-to-
cytoplasmic ratio and pleomorphism. Three or more criteria
present deﬁne malignancy, one or two deﬁne atypia, and
none or solely pleomorphism deﬁne benign tumours [7].
Sixteen out of seventeen (94.1%) specimens showed no
necrotic features, with one specimen (5.9%) displaying
elements of necrosis. Prominent nucleoli were seen in six out
of seventeen specimens (35.3%), and nuclear pleomorphism
in two out of seventeen specimens (11.8%). The mitotic
rate ranged from 0 to 2/10 high-power ﬁelds, which was
highest in the two atypical tumours. Typically, tumour cells
were diﬀusely and strongly positive for S100 protein by
immunohistochemistry; whereas the other markers tested
were negative. These included smooth muscle actin, desmin,
myogenin, and pankeratin MNF116.
No patients received chemotherapy or radiotherapy at
any point. One patient was lost to follow-up following
surgery. Mean follow-up of the remaining cases was 19.3
months following surgical excision (range 1–55 months).
T h e r ew e r en oc a s e so fl o c a lr e c u r r e n c e .O n ep a t i e n te x p e r i -
enced distant recurrence, representing with a supraclavicular
fossa tumour following intralesional excision of a thoracic
spine tumour. One patient developed Chronic Regional
Pain Syndrome post-operatively, which recovered following
conservative management.
4. Discussion
Granular cell tumours are rare and the literature relating
to them is sparse. Abrikossoﬀ was the ﬁrst to describe this
tumour in the literature in 1926 [1] as a myoblastoma, since
it was reported as a tumour arising from muscle in the
tongue. Over the following 60 years the tumour was thought
to be neural in origin since it was observed that tumours
arisingin theextremitieswererelatedtotheradialandsciatic
nerve trunks [3, 8, 9]. Current opinion concurs with this.
Lack et al. in 1980 [2] were the ﬁrst to scrutinise the
collectionofhistopathologicalspecimenslabelledasgranular
cell tumours in two centres and correlate them with clinical
presentation [2]. They reported on a total of 118 cases of
granular cell tumours in all localities. The most common site
wasthetonguealthoughgreaternumbersoftumoursseemed
to occur in the skin and subcutaneous tissues.
Tsuchida et al. reviewed the reported cases of granular
cell tumours in the English and Japanese literature [4].
They found a 2.9: 1 female to male preponderance for the
tumour and compared it with previous reported series (1.8:1
and average age 32 years [2]). 26.8% of cases were in theSarcoma 3
(a) (b)
Figure 1: Gross appearance of granular cell tumour. This is an example of multicentric granular cell tumour (case number 10). On the left
side (a), the tumour is poorly circumscribed solid and pale yellow, and shows inﬁltrative growth margin (paraspinal tumour). On the right
side (b) the tumour shows better deﬁned pushing margin (supraclavicular tumour).
(a) (b)
Figure 2: Typical histological appearance of granular cell tumour (a). Sheets of rounded and oval cells with large amount of ﬁne granular
eosinophilic cytoplasm. The nuclei are bland and eccentric (20×, H&E stain). Atypical granular cell tumour (b). In comparison with
Figure 2(a), there is nuclear pleomorphism, prominent eosinophilic nucleoli, and cell spindling. A mitosis is also present (arrow) (20×,
H&E stain).
lower extremities and previous reports showed that benign
tumours were uncommon (6.4%) in the lower extremities.
Of 11 lesions presenting in the upper and lower extremities
36% were within muscle and only 4% of those were benign.
The mode of presentation of granular cell tumours is
usually in the form of a painless mass and occurs most
commonly between the third and ﬁfth decades [2, 4, 7]. The
mean age in our series was 31.2 years. They occur more
commonly in women than in men and have preponderance
for patients of Afro-Caribbean race. The reported ratio of
female to male cases is 1.8–2.9: 1 [2, 4, 7] although in our
series the ratio was much higher at 9:1.
One feature of these tumours is that they may be
multicentric or multifocal at time of presentation. This
raises the suspicion of malignancy. The reported incidence
of multicentricity at time of presentation ranges between
5 and 16%. In our series we had one patient with two
separate lesions, one on the dorsal chest wall and another
in the supraclavicular fossa. Both lesions were benign. In
our opinion this represents multifocal rather than metastatic
disease.
Fanburg-Smith et al. [7] deﬁned the diagnostic criteria
for malignant granular cell tumours and correlated their
ﬁndings with previous series. They reported 73 cases, 284 Sarcoma
of which were malignant, 3 cases were multicentric and 9
cases were atypical. They found that the multicentric and
atypical cases all ran a benign course exhibiting no evidence
of metastasis and no deaths. They did, however, observe in
one multicentric case that a new tumour arose in a new
location. In the atypical group there were local recurrences
but no deaths after 8 years of follow-up. In 28 malignant
cases they had a 39% death rate with a median interval of 3
years compared with 50% at 2.8 years in the Tsuchida series
[4] .T h e yr e p o r t e dar a t eo fm e t a s t a s i so f5 0 % ,w i t hl y m p h
nodes and bone being the most common sites. Interestingly
the local recurrence rate of patients with metastasis was 32%
(compared with 50% in Tsuchida’s series).
The best radiological modality for characterisation is
Magnetic Resonance Imaging (MRI) [8]. Benign granular
cell tumours are classically iso-intense or brighter than
muscle on T1-weighted sequences, round or oval in shape,
superﬁcial in location, and 4cm or less in size. On T2-
weighted sequences, the signal from the central portion of
the lesion is classically iso-intense to muscle or suppressed
fat, with high signal peripherally. Malignant granular cell
tumours may demonstrate invasion of adjacent structures
and signal intensity characteristics that are often seen with
other aggressive neoplasms.
Histopathological examination classically reveals large
cellswithaneosinophilicgranularcytoplasm,aswasdemon-
strated in all specimens in our series. All granular cell
tumours tested S-100 positive [7]. The lack of melanosomes
and negative HMB45 immunostaining in granular cell
tumours help distinguish it from malignant melanoma.
The schwannian features of malignant peripheral nerve
sheath tumours (MPNST) and lack of S-100 staining help
distinguish them from granular cell tumours and therefore
enable exclusion from the diﬀerential diagnosis.
Malignant granular cell tumours comprise 1%-2% of all
granular cell tumours. They occur most commonly at 40–
50 years of age [4, 7], and in female patients. Tsuchida et al.
[4] report 26 out of 35 (74%) and Fanburg-Smith et al. [7]
report 32 out of 46 patients (70%). Risk of malignancy is
increased if tumour size is greater than 4cm at presentation
[7]. 91% of the resected tumours in our series had a longest
diameter of less than 42mm. Although the largest two of
these specimens had atypical features, no specimens in our
seriesweremalignant.Interestingly,byfarthelargesttumour
resected did not show any features of atypia or malignancy,
despite this being a distant recurrence. In our series, the
depth of the tumour, and tissue within which it arose had
no correlation with the risk of malignancy. The margin of
resection in our series bore no correlation with the risk of
malignancy or recurrence. It would be logical to hypothesise
thatintralesionalexcisionwouldgiverisetoanincreasedrisk
of local recurrence or metastasis, but this is not a trend that
we identiﬁed in our series.
In our series we had 100% patient survival rate at a
mean of 19.3 months post-operatively (range 1–55 months)
on a background of symptoms of mean duration 10.4
months (range 3–24). Survivorship has been described
as worsening with size greater than 4cm, female gender,
tumour presenting in the lower extremities, intramuscular
location, rapid recent growth, local recurrence, metastases,
Ki67 values greater than 10% and p53 immunoreactivity [7].
Radiotherapy and chemotherapy have not been shown to
signiﬁcantly improve the clinical course of the disease [10].
We present a series of eleven cases of granular cell
tumours in ten patients, with one case of distant recurrence.
All tumours were benign, although the largest two primary
tumours did display atypical histopathological features. In
our series, the depth of the tumour, the tissue in which
it was located, the size and the margins of resection all
bore no correlation with the risk of malignancy or short-
term survivorship. Medium-term and long-term follow-up
is required to elucidate this further.
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